Posted by Michael Wonder on 28 Aug 2019
FDA warns testing companies: don’t tell patients how their DNA influences response to specific drugs
28 August 2019 - Amid a boom in genetic testing that aims to predict a person’s response to medication, the FDA has been quietly pressuring a handful of companies to stop reporting results to patients about how their genes may interact with specific drugs.
The agency’s concern? That unsupported claims about gene-drug links could be dangerous, if they spur patients to start, stop, or switch medications in ways that aren’t appropriate.
